Lance Swift

Senior Medical Device Engineer at Vaxxas

Lance Swift has a diverse work experience spanning over several industries and roles. Lance is currently employed at Vaxxas as a Senior Medical Device Engineer. Prior to this, they held a short-term position as a Medical Device Engineer at the same company.

Before joining Vaxxas, Lance worked at NOJA Power Switchgear Ltd as a Procurement Value Engineer. In this role, they were responsible for achieving a 3% year-on-year BOM cost reduction by resourcing components and services to lower cost suppliers, negotiating better deals with existing suppliers, championing lower cost design solutions, and project managing their implementation.

Lance also has experience working at ResMed, where they served as the Team Leader

of Product Lifecycle Engineering for a year. Lance also worked as a Senior Engineer in Research and Technology Patient Interface Product Design from 2010 to 2012.

Earlier in their career, Lance held various senior engineering positions at NTC-Europe, including roles in safety strategy, interior trim design, and general engineering. Lance also worked as an Engineer at Secured By Design and Rover Group.

Overall, Lance Swift's work experience showcases their strong background in engineering, particularly in the medical device and power industries.

Lance Swift's education history includes attending Harvard Business School Online in 2020 to pursue a course in Negotiation Mastery. Prior to that, from 1984 to 1988, they studied at The University of Huddersfield where they obtained a Bachelor of Engineering (B.Eng. Hons) degree in Mechanical Design Engineering. Additionally, during the same period, they also attained a BEng hons degree in Mechanical Engineering at The University of Huddersfield.

Location

Capalaba, Australia

Links

Previous companies


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Vaxxas

Needle-free vaccination and vaccine delivery solutions that safely and cost effectively amplify vaccine efficacy using Nanopatch technology developed by Vaxxas.


Headquarters

Sydney, Australia

Employees

51-200

Links